NCT06245109View on ClinicalTrials.gov

Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis

PHASE4RecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

February 26, 2024

Primary Completion Date

March 15, 2028

Study Completion Date

March 15, 2028

Conditions
Knee Osteoarthritis
Interventions
DRUG

Duloxetine

60 mg, oral

DRUG

Celecoxib

200 mg, oral

DRUG

Placebo

Matching placebo, oral

Trial Locations (1)

60611

RECRUITING

Northwestern University, Chicago

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

lead

Northwestern University

OTHER